Reporting owner

O'DONNELL CAROL A

Reporting owner CIK 0001573840 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.O'DONNELL CAROL AO'DONNELL CAROL AO'DONNELL CAROL A · November 11, 2025 · Stock award · Stock Option (right to buy)O'DONNELL CAROL A · October 15, 2025 · Stock award · Stock Option (right to buy)Oct 15, 2025Nov 11, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 11, 2025Apimeds Pharmaceuticals US, Inc.Stock Option (right to buy)O'DONNELL CAROL AStock award
Oct 15, 2025Apimeds Pharmaceuticals US, Inc.Stock Option (right to buy)O'DONNELL CAROL AStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Apimeds Pharmaceuticals US, Inc.APUS · company listingsStock awardStock Option (right to buy)Derivative security · Code A10,0000Value: 0Currency not specifiedView ↗
Trade: Apimeds Pharmaceuticals US, Inc.APUS · company listingsStock awardStock Option (right to buy)Derivative security · Code A3,0000Value: 0Currency not specifiedView ↗